Inventor
WUSSOW FELIX
US15 patents
Patents
15 patentsUS10376575B2Aug 13, 2019
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY3 citations83
US9931395B2Apr 3, 2018
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY6 citations83
US11964006B2Apr 23, 2024
Multivalent Epstein-Barr virus-like particles and uses thereof
HOPE CITY2 citations68
US12150987B2Nov 26, 2024
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY0 citations62
US11844833B2Dec 19, 2023
Expression system for expressing herpesvirus glycoprotein complexes
HOPE CITY0 citations62
US11717568B2Aug 8, 2023
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY0 citations62
US11389529B2Jul 19, 2022
Expression system for expressing herpesvirus glycoprotein complexes
HOPE CITY0 citations62
US12303559B2May 20, 2025
Multivalent Epstein-Barr virus-like particles and uses thereof
HOPE CITY0 citations58
US11384137B2Jul 12, 2022
MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
HOPE CITY0 citations58
US12054736B2Aug 6, 2024
Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved stability and methods of preparation thereof
HOPE CITY0 citations55
US12156911B2Dec 3, 2024
Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereof
HOPE CITY0 citations52
US12527858B2Jan 20, 2026
MVA vectors for expressing multiple cytomegalovirus (CMV) antigens and use thereof
HOPE CITY0 citations51
US10842864B2Nov 24, 2020
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY0 citations51
US12584146B2Mar 24, 2026
Synthetic modified vaccinia Ankara (SMVA) based coronavirus vaccines
HOPE CITY0 citations47
US10487139B2Nov 26, 2019
MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
HOPE CITY0 citations47